PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
401,500
+8,000 (2.03%)
May 9, 2025, 3:30 PM KST
195.66%
Market Cap 4.17T
Revenue (ttm) 350.12B
Net Income (ttm) 92.04B
Shares Out 10.39M
EPS (ttm) 8,940.87
PE Ratio 44.91
Forward PE 31.43
Dividend 1,100.00 (0.28%)
Ex-Dividend Date Dec 27, 2024
Volume 55,281
Average Volume 67,419
Open 393,500
Previous Close 393,500
Day's Range 392,000 - 409,000
52-Week Range 121,300 - 409,000
Beta 0.53
RSI 67.19
Earnings Date May 9, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 409
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements

News

There is no news available yet.